U Petrausch
28.06.2012
Effector memory and central memory NY-ESO-1-specific re-directed T cells for treatment of multiple myeloma
Schuberth P, Renner C, Fox B, Bifulco C, Tinguely M, Thiel M, Held G, Mischo A, Haile S, Haley D, Gautschi F, Wadle A, Jensen S, Jakka G, Petrausch U. Effector memory and central memory NY-ESO-1-specific re-directed T cells for treatment of multiple myeloma. Gene Ther 2012
28.06.2012Effector memory and central memory NY-ESO-1-specific re-directed T cells for treatment of multiple myeloma
28.06.2012Gene Ther 2012
Schuberth P C, Renner C, Fox B A, Bifulco C B, Tinguely M, Thiel M, Held G, Mischo A, Haile Sarah, Haley D, Gautschi F, Wadle A, Jensen S M, Jakka G, Petrausch U
Weiter
05.02.2010
Risk-adapted FDG-PET/CT-based follow-up in patients with diffuse large B-cell lymphoma after first-line therapy
Petrausch U, Renner C, Mischo A, Hany T, Knuth A, Soyka J, Veit-Haibach P, Haile S, Samaras P, Schäefer N. Risk-adapted FDG-PET/CT-based follow-up in patients with diffuse large B-cell lymphoma after first-line therapy. Ann Oncol 2010; 21:1694-8.
05.02.2010Risk-adapted FDG-PET/CT-based follow-up in patients with diffuse large B-cell lymphoma after first-line therapy
05.02.2010Ann Oncol 2010; 21:1694-8
Petrausch U, Renner C, Mischo A, Hany T F, Knuth A, Soyka J D, Veit-Haibach P, Haile Sarah, Samaras P, Schäefer N G
Weiter